Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Telix Pharmaceuticals Limited | TLX | $10.03 | $3.41B | 100.3 | — |
| CareDx, Inc. | CDNA | $70.74 | $3.38B | 31.5 | — |
| Viking Therapeutics, Inc. | VKTX | $26.38 | $3.35B | — | |
| Tarsus Pharmaceuticals, Inc. | TARS | $70.50 | $3.30B | — | |
| Warby Parker Inc. | WRBY | $25.63 | $3.17B | 427.2 | — |
| Celcuity Inc. Common Stock | CELC | $61.56 | $3.09B | — | |
| Enliven Therapeutics, Inc. | ELVN | $41.82 | $3.06B | — | |
| Curaleaf Holdings, Inc. | CURA.TO | CA$11.38 | CA$3.01B | — | |
| Dyne Therapeutics, Inc. | DYN | $16.07 | $3.00B | — | |
| Denali Therapeutics Inc. Common Stock | DNLI | $18.68 | $2.99B | — | |
| AtriCure, Inc. | ATRC | $57.67 | $2.93B | 274.6 | — |
| Acadia Healthcare Company, Inc. | ACHC | $31.43 | $2.93B | — | |
| Disc Medicine, Inc. | IRON | $76.00 | $2.92B | — | |
| Privia Health Group, Inc. | PRVA | $22.47 | $2.87B | 107.0 | — |
| Nurix Therapeutics, Inc. | NRIX | $26.02 | $2.84B | 10.7 | — |
| Aveanna Healthcare Holdings Inc. | AVAH | $12.99 | $2.84B | 10.3 | — |
| Maravai LifeSciences Holdings, Inc. | MRVI | $7.57 | $2.80B | — | |
| Zai Lab Limited American Depositary Shares | ZLAB | $24.20 | $2.72B | — | |
| Viridian Therapeutics, Inc. | VRDN | $23.01 | $2.61B | — | |
| MBX Biosciences, Inc. | MBX | $53.93 | $2.60B | — | |
| Beam Therapeutics Inc. | BEAM | $24.84 | $2.57B | — | |
| Extendicare Inc. | EXE.TO | CA$27.08 | CA$2.57B | 20.7 | 1.93% |
| Neogen Corporation | NEOG | $11.79 | $2.57B | — | |
| Clover Health Investments, Corp. | CLOV | $4.78 | $2.55B | — | |
| NewAmsterdam Pharma Company N.V. | NAMS | $21.49 | $2.51B | — | |
| TransMedics Group, Inc. | TMDX | $72.40 | $2.51B | 18.8 | — |
| HUTCHMED (China) Limited | HCM | $14.37 | $2.50B | 143.7 | — |
| Guardian Pharmacy Services, Inc. | GRDN | $38.98 | $2.47B | 37.8 | — |
| ADMA Biologics, Inc. | ADMA | $11.01 | $2.47B | 15.7 | — |
| SELLAS Life Sciences Group, Inc. | SLS | $12.14 | $2.45B | — | |
| Brookdale Senior Living Inc. | BKD | $10.08 | $2.41B | — | |
| Arcus Biosciences, Inc. | RCUS | $19.10 | $2.40B | — | |
| Supernus Pharmaceuticals, Inc. | SUPN | $41.21 | $2.40B | — | |
| Precigen, Inc. | PGEN | $6.60 | $2.36B | — | |
| Fortrea Holdings Inc. | FTRE | $24.06 | $2.29B | — | |
| Pediatrix Medical Group, Inc. | MD | $28.10 | $2.28B | 13.1 | — |
| Prestige Consumer Healthcare Inc. | PBH | $47.92 | $2.27B | 13.4 | — |
| Aurinia Pharmaceuticals Inc. | AUPH | $16.90 | $2.25B | 7.4 | — |
| Vera Therapeutics, Inc. | VERA | $31.20 | $2.25B | — | |
| UFP Technologies, Inc. | UFPT | $290.11 | $2.25B | 31.3 | — |
| Harmony Biosciences Holdings, Inc. | HRMY | $38.31 | $2.23B | 12.4 | — |
| Sienna Senior Living Inc. | SIA.TO | CA$20.05 | CA$2.22B | 37.8 | 4.65% |
| Agios Pharmaceuticals, Inc. | AGIO | $37.18 | $2.22B | — | |
| Celldex Therapeutics, Inc. | CLDX | $29.37 | $2.22B | — | |
| Bausch Health Companies Inc. | BHC | $6.45 | $2.20B | — | |
| Addus HomeCare Corporation | ADUS | $117.95 | $2.20B | 20.7 | — |
| Perrigo Company plc | PRGO | $15.91 | $2.20B | 7.17% | |
| NeoGenomics, Inc. | NEO | $17.04 | $2.19B | — | |
| Alamar Biosciences, Inc. | ALMR | $31.45 | $2.18B | — | |
| Progyny, Inc. | PGNY | $28.44 | $2.18B | 30.9 | — |
Telix Pharmaceuticals Limited
Healthcare / Biotechnology
- Market Cap
- $3.41B
- P/E
- 100.3
CareDx, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $3.38B
- P/E
- 31.5
Viking Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.35B
- P/E
- unprofitable
Tarsus Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.30B
- P/E
- unprofitable
Warby Parker Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $3.17B
- P/E
- 427.2
Celcuity Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $3.09B
- P/E
- unprofitable
Enliven Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.06B
- P/E
- unprofitable
Curaleaf Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$3.01B
- P/E
- unprofitable
Dyne Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.00B
- P/E
- unprofitable
Denali Therapeutics Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $2.99B
- P/E
- unprofitable
AtriCure, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $2.93B
- P/E
- 274.6
Acadia Healthcare Company, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $2.93B
- P/E
- unprofitable
Disc Medicine, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.92B
- P/E
- unprofitable
Privia Health Group, Inc.
Healthcare / Health Information Services
- Market Cap
- $2.87B
- P/E
- 107.0
Nurix Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.84B
- P/E
- 10.7
Aveanna Healthcare Holdings Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $2.84B
- P/E
- 10.3
Maravai LifeSciences Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.80B
- P/E
- unprofitable
Zai Lab Limited American Depositary Shares
Healthcare / Biotechnology
- Market Cap
- $2.72B
- P/E
- unprofitable
Viridian Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.61B
- P/E
- unprofitable
MBX Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.60B
- P/E
- unprofitable
Beam Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $2.57B
- P/E
- unprofitable
Extendicare Inc.
Healthcare / Medical Care Facilities
- Market Cap
- CA$2.57B
- P/E
- 20.7
- Dividend Yield
- 1.93%
Neogen Corporation
Healthcare / Medical Devices
- Market Cap
- $2.57B
- P/E
- unprofitable
Clover Health Investments, Corp.
Healthcare / Healthcare Plans
- Market Cap
- $2.55B
- P/E
- unprofitable
NewAmsterdam Pharma Company N.V.
Healthcare / Biotechnology
- Market Cap
- $2.51B
- P/E
- unprofitable
TransMedics Group, Inc.
Healthcare / Medical Devices
- Market Cap
- $2.51B
- P/E
- 18.8
HUTCHMED (China) Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.50B
- P/E
- 143.7
Guardian Pharmacy Services, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $2.47B
- P/E
- 37.8
ADMA Biologics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.47B
- P/E
- 15.7
SELLAS Life Sciences Group, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.45B
- P/E
- unprofitable
Brookdale Senior Living Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $2.41B
- P/E
- unprofitable
Arcus Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.40B
- P/E
- unprofitable
Supernus Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.40B
- P/E
- unprofitable
Precigen, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.36B
- P/E
- unprofitable
Fortrea Holdings Inc.
Healthcare / Biotechnology
- Market Cap
- $2.29B
- P/E
- unprofitable
Pediatrix Medical Group, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $2.28B
- P/E
- 13.1
Prestige Consumer Healthcare Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.27B
- P/E
- 13.4
Aurinia Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $2.25B
- P/E
- 7.4
Vera Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.25B
- P/E
- unprofitable
UFP Technologies, Inc.
Healthcare / Medical Devices
- Market Cap
- $2.25B
- P/E
- 31.3
Harmony Biosciences Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.23B
- P/E
- 12.4
Sienna Senior Living Inc.
Healthcare / Medical Care Facilities
- Market Cap
- CA$2.22B
- P/E
- 37.8
- Dividend Yield
- 4.65%
Agios Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.22B
- P/E
- unprofitable
Celldex Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.22B
- P/E
- unprofitable
Bausch Health Companies Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.20B
- P/E
- unprofitable
Addus HomeCare Corporation
Healthcare / Medical Care Facilities
- Market Cap
- $2.20B
- P/E
- 20.7
Perrigo Company plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.20B
- P/E
- unprofitable
- Dividend Yield
- 7.17%
NeoGenomics, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $2.19B
- P/E
- unprofitable
Alamar Biosciences, Inc.
Healthcare / Medical Devices
- Market Cap
- $2.18B
- P/E
- unprofitable
Progyny, Inc.
Healthcare / Healthcare Plans
- Market Cap
- $2.18B
- P/E
- 30.9
Showing 201–250 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.